Status: current, Primitive. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3637621017 | Enasidenib | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3637622012 | Enasidenib (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Enasidenib | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Enasidenib | Is a | Antineoplastic agent | true | Inferred relationship | Some | ||
| Enasidenib | Is a | Aminopyridine | true | Inferred relationship | Some | ||
| Enasidenib | Has disposition | Isocitrate dehydrogenase-2 inhibitor | true | Inferred relationship | Some | ||
| Enasidenib | Is a | Isocitrate dehydrogenase-2 inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Enasidenib mesilate | Is modification of | True | Enasidenib | Inferred relationship | Some | |
| Enasidenib only product | Has active ingredient | True | Enasidenib | Inferred relationship | Some | 1 |
| Enasidenib only product in oral dose form | Has active ingredient | True | Enasidenib | Inferred relationship | Some | 1 |
| Enasidenib mesilate | Is a | False | Enasidenib | Inferred relationship | Some | |
| Enasidenib-containing product | Has active ingredient | True | Enasidenib | Inferred relationship | Some | 1 |
| Enasidenib-containing product in oral dose form | Has active ingredient | True | Enasidenib | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
Description inactivation indicator reference set
FHIR